|
|
Neuromuscular Diseases
- Neuromuscular
Disease Center at Washington University School of Medicine, St
Louis (US)
- Neuromuscular
& Central Nervous System Syndromes - Washington University
School of Medicine, St Louis (US)
- MEDLINE
- Viral
mediated expression of insulin-like growth factor I blocks the aging-related
loss of skeletal muscle function. Proc Natl Acad Sci U S A 1998
Dec 22;95(26):15603-7.Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal
N, Sweeney HL. Department of Physiology, A700 Richards Building, University
of Pennsylvania School of Medicine, Philadelphia, PA 19104-6085, USA.
- Role
of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium
leprae. Science 1998 Dec 11;282(5396):2076-9 .Rambukkana A, Yamada
H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, Campbell KP, Fischetti
VA
- Identification
of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis
virus and Lassa fever virus. Science 1998 Dec 11;282(5396):2079-81.
Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST,
Compans RW, Campbell KP, Oldstone MB
- A
pilot trial of prednisone in facioscapulohumeral muscular dystrophy.FSH-DY
Group. Neurology 1997 Jan;48(1):46-9. Tawil R, McDermott MP, Pandya
S, King W, Kissel J, Mendell JR, Griggs RC. Department of Neurology,
University of Rochester School of Medicine and Dentistry, NY 14642,
USA.
- Pilot
trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY
Group. Neurology 1998 May;50(5):1402-6. Kissel JT, McDermott MP,
Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R. Department
of Neurology, Ohio State University, Columbus 43210, USA.
- Myoblast
transfer in the treatment of Duchenne's muscular dystrophy. N
Engl J Med 1995 Sep 28;333(13):832-8. Mendell JR, Kissel JT, Amato
AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE,
Rice R, et al. Department of Neurology, Ohio State University, Columbus
43210, USA.
- Duchenne
dystrophy: randomized, controlled trial of prednisone (18 months)
and azathioprine (12 months). Neurology 1993 Mar;43(3 Pt 1):520-7.
Griggs RC, Moxley RT 3d, Mendell JR, Fenichel GM, Brooke MH, Pestronk
A, Miller JP, Cwik VA, Pandya S, Robison J, et al. Department of Neurology,
University of Rochester, NY.
- Expansion
of the myotonic dystrophy CTG repeat reduces expression of the flanking
DMAHP gene. Nat Genet 1997 Aug;16(4):407-9. Thornton CA, Wymer
JP, Simmons Z, McClain C, Moxley RT 3rd. Department of Neurology,
School of Medicine and Dentistry, University of Rochester, NY 14642,
USA.
- Myotonic
dystrophy: size- and sex-dependent dynamics of CTG meiotic instability,
and somatic mosaicism. Am J Hum Genet 1993 May;52(5):875-83.
Lavedan C, Hofmann-Radvanyi H, Shelbourne P, Rabes JP, Duros C, Savoy
D, Dehaupas I, Luce S, Johnson K, Junien C. INSERM, Unite 73, Paris,
France.
- Paternal
transmission of congenital myotonic dystrophy. J Med Genet 1994
Jul;31(7):518-20. Bergoffen J, Kant J, Sladky J, McDonald-McGinn
D, Zackai EH, Fischbeck KH. Department of Human Genetics and Molecular
Biology, Children's Hospital of Philadelphia, PA 19104.
- Mutations
in Emery-Dreifuss muscular dystrophy and their effects on emerin protein
expression. Hum Mol Genet 1998 May;7(5):855-64. Manilal
S, Recan D, Sewry CA, Hoeltzenbein M, Llense S, Leturcq F, Deburgrave
N, Barbot J, Man N, Muntoni F, Wehnert M, Kaplan J, Morris GE. MRIC
Biochemistry Group, NE Wales Institute, Wrexham LL11 2AW, UK.
|
